## **Core Concept**
Kawasaki Disease is an acute febrile illness of childhood characterized by vasculitis, particularly affecting the coronary arteries. The treatment aims to reduce inflammation, prevent coronary artery complications, and manage symptoms. The acute phase management is critical to prevent long-term cardiac sequelae.

## **Why the Correct Answer is Right**
The correct answer involves the administration of **intravenous immunoglobulin (IVIG)**. IVIG is the mainstay treatment for Kawasaki Disease in the acute phase. It works by reducing the duration of fever, decreasing the risk of coronary artery abnormalities, and modulating the immune response. The exact mechanism is not fully understood, but it is believed to involve the blockade of Fc receptors in the spleen, reduction of pro-inflammatory cytokine production, and neutralization of circulating toxins or pathogens.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although **aspirin** is used in the treatment of Kawasaki Disease, it is not the primary treatment in the acute phase. Aspirin is used for its anti-inflammatory and antiplatelet effects but does not replace the need for IVIG.
- **Option B:** This option might suggest another treatment, but without specifics, it's hard to directly refute. However, treatments like **steroids** are generally not recommended as a first-line treatment in the acute phase due to potential adverse effects on coronary arteries and the disease process.
- **Option D:** This option is incorrect because **plasmapheresis** or other treatments like **cyclosporine** might be considered in refractory cases but are not the first-line treatment for the acute phase of Kawasaki Disease.

## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is that **IVIG** should be administered within the first 10 days of illness onset to be most effective in preventing coronary artery complications. Additionally, **aspirin** is typically given at a high dose initially (80-100 mg/kg/day) and then reduced to a low dose (3-5 mg/kg/day) after fever resolution to prevent coronary artery thrombosis.

## **Correct Answer:** . IVIG (Intravenous Immunoglobulin)